ClinVar Genomic variation as it relates to human health
NM_000039.3(APOA1):c.178T>G (p.Ser60Ala)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance(3); Benign(2); Likely benign(1)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000039.3(APOA1):c.178T>G (p.Ser60Ala)
Variation ID: 879223 Accession: VCV000879223.11
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11q23.3 11: 116837023 (GRCh38) [ NCBI UCSC ] 11: 116707739 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 31, 2020 Jul 23, 2024 Feb 5, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000039.3:c.178T>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000030.1:p.Ser60Ala missense NM_001318017.2:c.178T>G NP_001304946.1:p.Ser60Ala missense NM_001318018.2:c.178T>G NP_001304947.1:p.Ser60Ala missense NM_001318021.2:c.-150T>G NC_000011.10:g.116837023A>C NC_000011.9:g.116707739A>C NG_012021.1:g.5600T>G LRG_767:g.5600T>G LRG_767t1:c.178T>G LRG_767p1:p.Ser60Ala - Protein change
- S60A
- Other names
- -
- Canonical SPDI
- NC_000011.10:116837022:A:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00043
Trans-Omics for Precision Medicine (TOPMed) 0.00051
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00054
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
APOA1 | - | - |
GRCh38 GRCh37 |
103 | 327 | |
APOA1-AS | - | - | GRCh38 | - | 213 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Benign (1) |
criteria provided, single submitter
|
Apr 27, 2017 | RCV001106513.4 | |
Benign (1) |
criteria provided, single submitter
|
Apr 27, 2017 | RCV001106514.4 | |
Uncertain significance (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 23, 2024 | RCV001873509.5 | |
Likely benign (1) |
criteria provided, single submitter
|
Dec 19, 2022 | RCV002411631.2 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Feb 5, 2024 | RCV003994213.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Familial visceral amyloidosis, Ostertag type
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001263586.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. (less)
|
|
Benign
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Hypoalphalipoproteinemia, primary, 1
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001263587.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. (less)
|
|
Uncertain significance
(Jan 21, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002304790.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces serine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 60 of the APOA1 protein (p.Ser60Ala). … (more)
This sequence change replaces serine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 60 of the APOA1 protein (p.Ser60Ala). This variant is present in population databases (rs199759119, gnomAD 0.06%). This missense change has been observed in individual(s) with APOA1-related disease (PMID: 17303779, 20884842, 21820994, 30333156, 32041611). This variant is also known as S36A. ClinVar contains an entry for this variant (Variation ID: 879223). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt APOA1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects APOA1 function (PMID: 20884842). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Uncertain significance
(Feb 05, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV004813505.1
First in ClinVar: Apr 15, 2024 Last updated: Apr 15, 2024 |
Comment:
Variant summary: APOA1 c.178T>G (p.Ser60Ala) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging … (more)
Variant summary: APOA1 c.178T>G (p.Ser60Ala) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00068 in 1614034 control chromosomes in the gnomAD database, including 2 homozygotes. c.178T>G (also known as S36A) has been reported in the literature in individuals affected with APOA1-Related Disorders and individuals from low level high-density lipoprotein cholesterol (HDL-C)cohort studies (examples: Kiss_2007, Weers_2011, Rowcenio_2011, Haase_2012, Morrison_2013, Morrison_2013, Geller_2018, Dron_2020, Dong_2022). These report(s) do not provide unequivocal conclusions about association of the variant with APOA1-Related Disorders. At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Weers_2011). The following publications have been ascertained in the context of this evaluation (PMID: 32041611, 25972569, 35460704, 30333156, 17303779, 23770607, 21820994, 20884842). ClinVar contains an entry for this variant (Variation ID: 879223). Based on the evidence outlined above, the variant was classified as uncertain significance. (less)
|
|
Likely benign
(Dec 19, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiovascular phenotype
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002716204.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of … (more)
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. (less)
|
|
Uncertain significance
(Jan 23, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV005078443.1
First in ClinVar: Jul 23, 2024 Last updated: Jul 23, 2024 |
Comment:
Published functional studies suggest a damaging effect on APOA1 activity (PMID: 20884842); In silico analysis supports that this missense variant does not alter protein structure/function; … (more)
Published functional studies suggest a damaging effect on APOA1 activity (PMID: 20884842); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 17303779, 21820994, 23209431, 23770607, 30333156, 34426522, 20884842, 32041611) (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia. | Dong W | Journal of lipid research | 2022 | PMID: 35460704 |
Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias. | Dron JS | BMC medical genomics | 2020 | PMID: 32041611 |
Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. | Geller AS | Journal of lipid research | 2018 | PMID: 30333156 |
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study. | Haase CL | Diabetes | 2015 | PMID: 25972569 |
Whole-genome sequence-based analysis of high-density lipoprotein cholesterol. | Morrison AC | Nature genetics | 2013 | PMID: 23770607 |
Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach. | Haase CL | PLoS genetics | 2012 | PMID: 23209431 |
Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. | Rowczenio D | The American journal of pathology | 2011 | PMID: 21820994 |
Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation. | Weers PM | Journal of lipid research | 2011 | PMID: 20884842 |
Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects. | Kiss RS | Arteriosclerosis, thrombosis, and vascular biology | 2007 | PMID: 17303779 |
Text-mined citations for rs199759119 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.